SH Kim, N Bianco, R Menon,
ER Lechman… - Molecular therapy, 2006 - cell.com
We previously have demonstrated the ability of primary murine bone marrow-derived DC
(BM-DC), genetically modified by adenoviral infection to express FasL, to inhibit progression …